ABA
BIIB icon

American Beacon Advisors’s Biogen BIIB Stock Holding History

American Beacon Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-459
Closed -$162K – 27
2018
Q3 		$162K Buy
459
+60
+15% +$20.7K 1.1% 40
2018
Q2 		$116K Hold
399
– – 1.07% 51
2018
Q1 		$109K Buy
399
+38
+11% +$11.8K 1.16% 48
2017
Q4 		$115K Buy
361
+41
+13% +$13.2K 1.23% 48
2017
Q3 		$100K Buy
+320
New +$94.8K 1.19% 46

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

American Beacon Advisors's BIIB Position: Q4 2018 in Review

American Beacon Advisors sold out of Biogen (BIIB) in Q4 2018, closing a stake of 459 shares — an estimated $162K sold.

American Beacon Advisors first reported a position in BIIB in Q3 2017 and held it in 5 quarters. The position peaked at $162K in Q3 2018. 1,140 funds tracked by Wall St. Rank hold BIIB as of Q4 2018.

  • American Beacon Advisors reported no remaining Biogen position as of Q4 2018 after selling out during the quarter.
  • American Beacon Advisors sold 459 Biogen shares in Q4 2018, an estimated $162K.
  • American Beacon Advisors first reported a position in Biogen in Q3 2017 and held it in 5 quarters.
  • American Beacon Advisors's Biogen position peaked at $162K in Q3 2018.
  • 1,140 funds tracked by Wall St. Rank held Biogen as of Q4 2018.

Based on American Beacon Advisors's 13F filing for Q4 2018, filed 15 Feb 2019.